Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

SUMMARY: Addition of 10 mg prednisone daily to a methotrexate-based tight control strategy does not lead to bone loss in early rheumatoid arthritis (RA) patients receiving preventive treatment for osteoporosis. A small increase in lumbar bone mineral density (BMD) during the first year of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Goes, M. C., Jacobs, J. W. G., Jurgens, M. S., Bakker, M. F., van der Veen, M. J., van der Werf, J. H., Welsing, P. M. J., Bijlsma, J. W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604583/
https://www.ncbi.nlm.nih.gov/pubmed/23011680
http://dx.doi.org/10.1007/s00198-012-2073-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604583/
https://www.ncbi.nlm.nih.gov/pubmed/23011680
http://dx.doi.org/10.1007/s00198-012-2073-z

Ejemplares similares